Medicine
Amiodarone 150 mg/100 mL injection
Amiodarone 150 mg/100 mL injection is a generic prescription medicine for intravenous use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from freezing. Store at 20° - 25°C (68° - 77°F), excursions permitted…
Key facts
- Active ingredient (INN)
- Amiodarone
- Brand
- Sold under the generic name
- Strength
- 150 mg/100 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 bag of 100 mL
- Manufacturer
- HealthFirst
- Origin register
- US FDA, United States
- Storage
- Protect from freezing. Store at 20° - 25°C (68° - 77°F), excursions permitted to 15° - 30°C (59° - 86°F). See USP Controlled Room Temperature. Protect from light and excessive heat.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01BD01 Amiodarone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 29 January 2020
- Identifiers
- RxCUI 849876, 1046406DailyMed set ID 9d4d66f7-fa14-e832-e053-2a95a90a8b62NDC 51662-1480Application NDA022325
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bag in 1 carton / 100 mL in 1 bag | 51662-1480-1 | HealthFirst | 29 January 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 December 1985 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Amiodarone 150 mg/100 mL injection.
Other strengths and forms of Amiodarone
Clinical summary
Amiodarone is an antiarrhythmic indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. MedsAcross supplies Amiodarone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AmiodaroneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Nexterone prescribing information (Baxter Healthcare) · U.S. National Library of Medicine, DailyMed
Need Amiodarone 150 mg/100 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.